Search - tctmd.com

Displaying 761 - 780 of 989

Sort: Relevancy | Date

News Daily News

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

Yael L. Maxwell

September 02, 2014

News Conference News ESC 2014

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

Caitlin E. Cox

September 01, 2014

News Conference News ESC 2014

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Todd Neale

September 01, 2014

News Conference News ESC 2014

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Todd Neale

August 31, 2014

News Conference News ESC 2014

Observational Studies Ask How Much Medication Adherence Matters After MI

Caitlin E. Cox

August 31, 2014

News Industry News

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

August 31, 2014

News Industry News

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

August 30, 2014

News Industry News

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

August 27, 2014

News Industry News

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

August 25, 2014

News Daily News

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

L.A. McKeown

August 20, 2014

News Industry News

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

August 11, 2014

News Industry News

Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

August 07, 2014

News Daily News

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

Yael L. Maxwell

July 24, 2014

News Daily News

PARTNER Analyses Highlight Mortality Curves After TAVR

Caitlin E. Cox

July 17, 2014

News Industry News

Physicians Implant World's First ProMRI® Quadripolar CRT-D System to Treat

July 15, 2014

News Daily News

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Yael L. Maxwell

July 10, 2014

News Daily News

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

June 27, 2014

News Industry News

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

June 27, 2014

News Daily News

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

June 27, 2014

News Daily News

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

Yael L. Maxwell

June 24, 2014

Advertisement

Assessing Aortic Valve Calcification May Help Predict Paravalvular Leak After TAVR

NOMI: Nitric Oxide May Do Wonders for STEMI But Not When Mixed with Nitroglycerin

FAMOUS-NSTEMI: FFR Guidance Reduces Revascularization in NSTEMI

Registry Outcomes Match Positive Trial Findings for Repositionable TAVR Device

Observational Studies Ask How Much Medication Adherence Matters After MI

Large-scale Study Confirms Growing Body of Clinical Evidence for the St. Jude Medical Quadripolar System

Boston Scientific Announces Primary Endpoint Results of NECTAR-HF Clinical Trial

Medtronic Announces First Implants in Largest-Ever, Global Trial of Cardiac Resynchronization Therapy

Medtronic Viva® Cardiac Resynchronization Therapy-Pacemaker Now Available in U.S.

Similar Survival Benefits from Surgery, MitraClip in Symptomatic, High-Risk Mitral Regurgitation

Novartis to showcase heart failure leadership at ESC Congress 2014 with results on new first of its type medicine LCZ696

Medtronic Receives FDA Approval for Attain Performa® Quadripolar Lead and Viva® Quad CRT-Ds in United States

New CMR-Identified Myocardial Injury Post-TAVR Linked With Decreased LV Function

PARTNER Analyses Highlight Mortality Curves After TAVR

Physicians Implant World's First ProMRI® Quadripolar CRT-D System to Treat

Patient Traits Predict Need for Permanent Pacemaker After TAVR

Una Mayor Regresión Precoz de la Masa VI Post-TAVR Reduce las Rehospitalizaciones

Thoratec Announces First HeartMate III™ Human Implant And Start Of CE Mark Trial

Greater Early LV Mass Regression After TAVR Reduces Rehospitalization

La Dominancia Coronaria Influye en el Riesgo Precoz de Mortalidad Post-STEMI

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content